Mogrify
Mogrify® is a biopharmaceutical company focused on transforming the development of ex vivo cell therapies and pioneering the field of in vivo reprogramming therapies.
Last updated on
About Mogrify
Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$38MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologySIC Code
87NAICs Code
541Location
City
CambridgeState
CambridgeshireCountry
United KingdomTech Stack (82)
